BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15701835)

  • 21. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer.
    Zhao B; Bepler G
    Oncogene; 2001 Dec; 20(56):8154-64. PubMed ID: 11781830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of four new PITX2 gene mutations in patients with Axenfeld-Rieger syndrome.
    Vieira V; David G; Roche O; de la Houssaye G; Boutboul S; Arbogast L; Kobetz A; Orssaud C; Camand O; Schorderet DF; Munier F; Rossi A; Delezoide AL; Marsac C; Ricquier D; Dufier JL; Menasche M; Abitbol M
    Mol Vis; 2006 Dec; 12():1448-60. PubMed ID: 17167399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
    Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
    Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations truncating the EP300 acetylase in human cancers.
    Gayther SA; Batley SJ; Linger L; Bannister A; Thorpe K; Chin SF; Daigo Y; Russell P; Wilson A; Sowter HM; Delhanty JD; Ponder BA; Kouzarides T; Caldas C
    Nat Genet; 2000 Mar; 24(3):300-3. PubMed ID: 10700188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular processes of chromosome 9p21 deletions in human cancers.
    Sasaki S; Kitagawa Y; Sekido Y; Minna JD; Kuwano H; Yokota J; Kohno T
    Oncogene; 2003 Jun; 22(24):3792-8. PubMed ID: 12802286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
    Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
    Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.
    Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y
    Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.
    Uchida K; Nagatake M; Osada H; Yatabe Y; Kondo M; Mitsudomi T; Masuda A; Takahashi T; Takahashi T
    Cancer Res; 1996 Dec; 56(24):5583-5. PubMed ID: 8971158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers.
    Kim TM; Yim SH; Lee JS; Kwon MS; Ryu JW; Kang HM; Fiegler H; Carter NP; Chung YJ
    Clin Cancer Res; 2005 Dec; 11(23):8235-42. PubMed ID: 16322280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
    Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitment.
    Barbacci E; Chalkiadaki A; Masdeu C; Haumaitre C; Lokmane L; Loirat C; Cloarec S; Talianidis I; Bellanne-Chantelot C; Cereghini S
    Hum Mol Genet; 2004 Dec; 13(24):3139-49. PubMed ID: 15509593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling.
    Conde E; Angulo B; Tang M; Morente M; Torres-Lanzas J; Lopez-Encuentra A; Lopez-Rios F; Sanchez-Cespedes M
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):710-7. PubMed ID: 16467080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
    Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
    Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the homeodomain gene EMX2: sequence conservation, expression analysis, and a search for mutations in endometrial cancers.
    Noonan FC; Mutch DG; Ann Mallon M; Goodfellow PJ
    Genomics; 2001 Aug; 76(1-3):37-44. PubMed ID: 11549315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutations and deletions in the znfn1a1/ikaros gene in chemically induced murine lymphomas.
    Karlsson A; Söderkvist P; Zhuang SM
    Cancer Res; 2002 May; 62(9):2650-3. PubMed ID: 11980663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of BAF57 mutations in human breast cancer cell lines.
    Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
    Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.